Latest news on Laboratorytalk categorised by supplier
Asinex
Address:
6 Schukinskaya St
Moscow
123182
Russia
Telephone: (Russia) +7 095 190 7960
http://www.asinex.com
Our RSS feed for news from Asinex
Request to receive our free email newsletter each week
Listing of all 11 news releases from Asinex:
Milestone reached in drug discovery deal
Asinex has achieved screening results which have met the set criteria of Biovitrum for an undisclosed GPCR target
News from Asinex (13 July 2005)
Collaborating over bone and joint drugs
Galapagos and Asinex have initiated an integrated drug discovery collaboration in bone and joint diseases
News from Asinex (16 May 2005)
Sharing risks in drug discovery
Biovitrum will access Asinex's highly competitive drug discovery capabilities, including novel libraries of drug-like molecules and expertise in lead development and optimisation
News from Asinex (29 November 2004)
Integrated drug discovery project
Asinex and Recordati announce an integrated drug discovery collaboration in the area of micturition disorders
News from Asinex (25 October 2004)
Collaboration for lead generation
Computational department will create different pharmacophore models and use the results to rank the whole in-house Asinex library
News from Asinex ( 2 April 2004)
Successful bioscreening project
User application article Proteom, an in silico molecular design company, and Asinex, a company involved in lead generation and optimisation, have announced the completion of a successful bioscreening project
News from Asinex ( 5 February 2004)
Lead optimisation deal extended
Asinex has agreed a one year prolongation to its multi-FTE deal with Avalon Pharmaceuticals, a next-generation genomics-based company
News from Asinex (23 January 2004)
Lead optimisation project with Asahi Kasei
Asinex is performing optimisation of a hit compound provided by Japanese pharmaceutical company Asahi Kasei at its facilities in Moscow
News from Asinex ( 8 October 2003)
Drug discovery collaboration
Agreement to carry out screening against a variety of targets and whole cell screens using established library of compounds
News from Asinex ( 2 September 2003)
JandJ contract extended
Asinex announces a one year extension to collaboration with Johnson and Johnson Pharmaceutical research and development, a division of Janssen Pharmaceutica
News from Asinex (24 July 2003)
Multi-FTE deal with Biovitrum
Provider of lead generation and optimisation services will perform chemical lead optimisation of compounds for biotech company
News from Asinex (14 April 2003)
